President Urges Breaking Down Of Drug, Device Distinctions, Regulatory Barriers
This article was originally published in The Gray Sheet
The White House held a summit on its Precision Medicine Initiative where President Obama emphasized the need to break down outmoded regulations, and suggested that the barriers between drug and device oversight need to be loosened. Also at the meeting: FDA and NIH announced new competitions and projects, including the launch of an effort to gather data from a million Americans over the next few years.
Register for our free email digests: